My Size, INC 8-K filings

My Size, Inc. announced a 53% year-over-year revenue increase for Q2 2026, reaching $3.1 million, but also reported a widening net loss and declining gross margins.

My Size, Inc. has completed a 1-for-8 reverse stock split to boost its share price and comply with Nasdaq listing rules.

My Size, Inc. has entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, LLC Series 5, allowing for the sale of up to $10 million in common stock over 36 months.

My Size, Inc. announced the results of its 2026 annual meeting, with shareholders approving director elections, executive compensation advisory vote, and a reverse stock split authorization, while rejecting a blank check preferred stock amendment.

MySize, Inc. announced first quarter 2026 results, showcasing a 62% year-over-year revenue increase to $2.39 million and a significant improvement in gross margin to 39.3%.

My Size, Inc. received a notice from Nasdaq regarding non-compliance with the minimum $1.00 bid price requirement, initiating a 180-day compliance period.

MySize, Inc. announced estimated preliminary financial results for 2025, projecting $10 million in revenue and outlining a path to $15 million in 2026, driven by its integrated AI-driven sizing and commerce platform.

My Size, Inc. announced its Compensation Committee approved restricted stock awards for executive officers under its 2017 Equity Incentive Plan.

MySize, Inc. announced strong third-quarter 2025 financial results, featuring sequential revenue growth and margin expansion driven by its global technology platforms and European secondhand marketplace.

My Size, Inc. has acquired European AI-powered footwear sizing company ShoeSize.Me, integrating it into its Naiz Fit platform to create a unified apparel and footwear sizing solution.

My Size, Inc. stockholders approved the expansion of its 2017 Equity Incentive Plan, the election of two Class I directors, and the ratification of its independent public accountant at the 2025 Annual Meeting.

MySize, Inc. reported narrowed losses and a 2% year-over-year revenue increase in Q2 2025, driven by its Percentil acquisition, positioning itself in Europe's circular fashion economy.

My Size, Inc. announced a significant reduction in the exercise price of executive stock options and accelerated the vesting of restricted shares for its former Chief Financial Officer, reflecting adjustments to compensation arrangements.

MySize Inc. expands into the circular fashion market by acquiring key assets of Percentil, a second-hand fashion marketplace, aiming for profitability and strategic alignment with EU regulatory changes.

MySize, Inc. announces its 2024 full-year financial results, highlighting an 18% increase in revenue and a significant boost in cash reserves.

My Size, Inc. announces the appointment of Oren Elmaliah as CFO and Roy Golan as a Class I director, effective April 1, 2025, and immediately, respectively, following the resignation of the previous CFO, Or Kles, and Mr. Elmaliah stepping down as a board member.

My Size, Inc. has entered into an agreement with H.C. Wainwright & Co., LLC to offer and sell shares of its common stock, with an aggregate offering price of up to $4.1 million, through an at-the-market offering.

My Size, Inc. has announced that its Chief Financial Officer, Or Kles, will resign effective March 31, 2025, due to personal reasons.

My Size, Inc. successfully held its 2024 annual meeting, electing a Class III director and ratifying the appointment of its independent public accountant.

My Size, Inc. received approximately $3 million in gross proceeds from the exercise of warrants issued in a prior repricing transaction.

MySize, Inc. reports a 23% year-over-year revenue growth for 2024 and projects $15 million in revenue for 2025, driven by technology advancements and strategic market expansion.

MySize, Inc. announced a 53% increase in revenue and a 61% rise in gross profit for the second quarter of 2024, driven by growth in its Orgad and Naiz Fit businesses.

MySize Inc. announced a 314% increase in revenue to $2.98 million for the first quarter of 2024, driven by the acquisition of Orgad and growth in SaaS revenues.

My Size, Inc. has entered into an agreement with a warrant holder to exercise existing warrants at a reduced price, generating approximately $3.26 million in gross proceeds and issuing new warrants.

My Size, Inc. has successfully regained compliance with Nasdaq's minimum bid price rule after its stock price closed at or above $1.00 for ten consecutive business days.

My Size, Inc. has announced a 1-for-8 reverse stock split of its common stock, effective April 19, 2024, to increase its share price and regain compliance with Nasdaq listing requirements.

My Size, Inc. has granted restricted stock awards to three key executives, Ronen Luzon, Or Kles, and Billy Pardo, which will vest over three years.

My Size, Inc. will delist from the Tel Aviv Stock Exchange (TASE) with trading ceasing on March 27, 2024, and the delisting effective March 31, 2024, while maintaining its Nasdaq listing.